8-(2-Propenylamino)adenosine | 402724-88-3

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘌呤核苷
• 英文名称: 8-(2-Propenylamino)adenosine
• 英文别名: (2R,3R,4S,5R)-2-[6-amino-8-(prop-2-enylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
• CAS: 402724-88-3
• 化学式: C₁₃H₁₈N₆O₄
• 分子量: 322.324
• InChiKey: FECURFWCESRSEY-WOUKDFQISA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  23
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  152
• 氢给体数：
  5
• 氢受体数：
  9

文献信息

• Anti-HCV nucleoside derivatives
  申请人：——

  公开号：US20030008841A1

  公开（公告）日：2003-01-09

  The present invention comprises novel and known purine and pyrimidine nucleoside derivatives which have been discovered to be active against hepatitis C virus (HCV). The use of these derivatives for the treatment of HCV infection is claimed as are the novel nucleoside derivatives disclosed herein.

  本发明涉及新颖和已知的嘌呤和嘧啶核苷衍生物，已发现这些衍生物对丙型肝炎病毒（HCV）具有活性。本发明声明利用这些衍生物治疗HCV感染，以及本文所披露的新颖核苷衍生物。
• C2, 8-disubstituted adenosine derivatives and their different uses
  申请人：——

  公开号：US20040116374A1

  公开（公告）日：2004-06-17

  Novel C2, 8-disubstituted adenosine derivatives disclosed herein have been found to be potent adenosine receptor agonists, in particular for the A2A receptor. The said compounds have biological activity against conditions such as hypertension, ischemic heart disease, ischemic brain disease, psychosis and wound healing. Further, the invention also discloses a process for the preparation of such compounds and pharmaceutical compositions comprising them.

  本发明公开了 Novel C2，8-二取代腺苷衍生物，发现其是有效的腺苷受体激动剂，特别是对于A2A受体。所述化合物对高血压、缺血性心脏病、缺血性脑病、精神病和伤口愈合等疾病具有生物活性。此外，本发明还公开了制备这些化合物的方法和包含它们的药物组合物。
• NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP1315736A2

  公开（公告）日：2003-06-04
• C2, 8-DISUBSTITUTED ADENOSINE DERIVATIVES AND THEIR DIFFERENT USES
  申请人：Universiteit Leiden

  公开号：EP1368364A1

  公开（公告）日：2003-12-10
• US7112574B2
  申请人：——

  公开号：US7112574B2

  公开（公告）日：2006-09-26